James P Mackin
CIK 1408470 · President & CEO · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$42.02M
Companies
5
Total Filings
92
Lifetime Open-Market Net
-$28.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AORT | President & CEO | 965,162 | $28.27 | $27.29M | -$16.83M | 31 | 2026-03-04 |
| CRY | President & CEO | 333,647 | $17.59 | $5.87M | -$11.49M | 33 | 2021-05-04 |
| Wright Medical Group N.V. (WMGI) Delisted | Director | 11,720 | — | — | $0 | 1 | 2019-07-30 |
| Wright Medical Group N.V. (WMGIZ) Delisted | Director | 7,804 | — | — | $0 | 1 | 2018-07-26 |
| MDT | SVP & Pres CRDM | 97,790 | $90.63 | $8.86M | -$398.1K | 14 | 2010-11-02 |
Recent Filings · Page 2 of 10
92 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-02 | AORT | Notice (144) | −30,921 | -$1.43M | EDGAR |
| 2025-11-14 | AORT | Sell (S) | −34,210 | -$1.57M | EDGAR |
| 2025-11-13 | AORT | Notice (144) | −34,210 | -$1.57M | EDGAR |
| 2025-11-12 | AORT | Notice (144) | −17,580 | -$784.4K | EDGAR |
| 2025-11-12 | AORT | Sell (S) | −17,580 | -$784.4K | EDGAR |
| 2025-08-19 | AORT | Sell (S) | −12,500 | -$529.0K | EDGAR |
| 2025-08-15 | AORT | Notice (144) | −12,500 | -$529.0K | EDGAR |
| 2025-03-10 | AORT | Mixed | +102,877 | -$561.3K | EDGAR |
| 2025-03-06 | AORT | Notice (144) | −70,700 | -$1.75M | EDGAR |
| 2025-03-04 | AORT | Grant (A) | +98,524 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.